Histologically defined biomarkers in toxicology

Expert Opinion on Drug Safety

Volumn 6, Issue 2, 2007, Pages 207-215

  Kilty, Cormac G ^a   Keenan, Joe ^a   Shaw, Martin ^a  

^a Biotrin International   (Ireland)

Author keywords

ALT; AST; Cardiotoxicity; Clara cell protein; Diabetes; GLDH; Glutathione S transferase; Hepatotoxicity; Histomics; NAG; Nephrotoxicity; Proteomics; Pulmonary toxicity; RPA 1; Sorbitol dehydrogenase; Troponin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOGLYCOSIDE DERIVATIVE; AMINOTRANSFERASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CISPLATIN; CLARA CELL PROTEIN; CREATINE KINASE MB; CREATININE; CYCLOSPORIN A; DOXORUBICIN; GENTAMICIN; GLUTAMATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE ALPHA; IDITOL DEHYDROGENASE; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; OZONE; TOSYLCHLORAMIDE SODIUM; TROPONIN;

AMINOTRANSFERASE BLOOD LEVEL; BIOASSAY; CARDIOTOXICITY; CELL TYPE; CELLULAR DISTRIBUTION; CLARA CELL; COST BENEFIT ANALYSIS; COST CONTROL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DRUG RESEARCH; ENZYME ACTIVITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; KUPFFER CELL; LIVER CELL; LIVER TOXICITY; LUNG TOXICITY; NEPHROTOXICITY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STANDARDIZATION; TISSUE DISTRIBUTION; TOXICITY TESTING;

ANIMALS; BIOLOGICAL MARKERS; HISTOLOGICAL TECHNIQUES; HUMANS; ORGAN SPECIFICITY; PHARMACEUTICAL PREPARATIONS; TOXICOLOGY;

EID: 33847719092     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.2.207     Document Type: Review

References (48)

1. EZZELL C: The price of pills. Does it really take $897 million for a new therapy? Sci. Am. (2003) 289(1):25.
2. DE JONG PE, NYNKE HALBESMA N, GANSEVOORT RT: Screening for early chronic kidney disease - what method fits best? Nephrol. Dial. Transplant. (2006) 21(9):2358-2361.
3. CLAMPITT RB, HART RJ: The tissue activities of some diagnostic enzymes in some mammalian species. J. Camp Pathol. (1978) 88:607-621.
4. KOH E, NAKAMURA T, TAKAHASHI H: Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats. Circ. J. (2004) 68(2):163-167.
5. AUNER HW, TINCHON C, LINKESCH W et al.: Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies. Ann. Hematol. (2003) 82(4):218-222.
6. HERMAN EH, ZHANG J, RIFAI N et al.: The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother. Pharmacol. (2001) 48(4):297-304.
7. KATIRJ B, AL JAHERI MM: Creatinine kinase revisited. J. Neuromusc. Dis. (2001) 2:158-163.
8. SPARANO JA, BROWN DL, WOLFF AC: Predicting cancer therapy-induced cardiotoxicity: the role of troponin and other markers. Drug Saf. (2002) 25(5):301-311.
9. SPECCHIA G, BUQUICCHIO C, PANSINI N et al.: Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. J. Lab. Clin. Med. (2005) 145(4):212-220.
10. HERMAN EH, ZHANG J, LIPSHULTZ SE et al.: Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J. Clin. Oncol. (1999) 17(7):2237-2243.
11. WALLACE KB, HAUSNER E, HERMAN E et al.: Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol. Pathol. (2004) 32:106-121.
12. ARSALANE K, BROECKAERT F, KNOOPS B et al.: Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone. Toxicol. Appl. Pharmacol. (1999) 159(3):169-174.
13. BERNARD A, CARBONNELLE S, NICKMILDER M, DE BURBURE C: Non-invasive biomarkers of pulmonary damage and inflammation: application to children exposed to ozone and trichloramine. Toxicol. Appl. Pharmacol. (2005) 206(2):185-190.
14. BALLET F: Heparotoxicity in drug development: detection, significance and solutions. J. Hepatol. (1997) 26(Suppl. 2):26-36.
15. TRULL AK, FACEY SP, REES GW et al.: Serum α-glutathione S-transferase: a sensitive marker of hepatocellular damage associated with liver allograft rejection. Transplantation (1994) 58:1345-1351.
16. GIFFEN PS, PICK CR, PRICE MA, WILLIAMS A, YORK M: Alpha-glutathione S-transferase in the assessment of hepatotoxicity - its diagnostic utility in comparison with other recognized markers in the Wistar Han rat. Toxicol. Pathol. (2002) 30(3):365-372.
17. O'BRIEN PJ, SLAUGHTER MR, POLLEY SR, KRAMER K: Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab. Anita. (2002) 36(3):313-321.
18. WOODMAN DD: Assessment of hepatotoxicity. In: Animal Clinical Chemistry a primer for toxicologists. Evans GO (Ed.), Taylor & Francis Publishers, UK (1996):71-86.
19. SCHMIDT ES, SCHMIDT FW: Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin. Chim. Acta. (1988) 43:43-56.
20. SONI MG, MANGIPUDY RS, MUMTAZ MM, MEHENDALE HM: Tissue repair response as a function of dose during trichloroethylene hepatotoxicity. Toxicol. Sci. (1998) 42(2):158-165.
21. SHAW M: The use of histologically defined specific biomarkers in drug development with special reference to the glutathione S-transferases. Cancer Biomark. (2005) 1:69-74.
22. BECKETT GJ, HAYES JD: Glutathione S-transferase measurements and liver disease in man. J. Clin. Biochem. Nutr. (1987) 2:1-24.
23. REES GR, TRULL AK, DOYLE S: Evaluation of an enzyme immunometric assay for serum α-glutathione S-transferase. Ann. Clin. Biochem. (1995) 32:575-583.
24. BORAN M, ÇETIN S: The role of α glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C infection undergoing high dose Interferon α-2b therapy. Nephron (1995) 82:22-26.
25. COLUCCIO D, NICKLAUS R, SCHNEIDER S, LEWIS M, HALL L: A study to evaluate biotrin rat alpha-glutathione S-transferases (alpha-GST) enzyme immunoassay (EIA) and its value to detect liver changes compared to standard liver enzymes, American Association of Clinical Chemists. 52nd Annual Meeting, San Francisco, CA, USA. Clin. Chem. (2000) 46:A140.
26. SUNDBERG AGM, NILSON R, APPELKVIST A-L, DALLNER G: Immunohistochemical localisation of alpha and pi class glutathione S-transferases in normal human tissues. Pharmacol. Toxicol. (1993) 72:321-331.
27. TEE LBG, GILMORE KS, MEYER DG et al.: Expression of glutathione S-transferase during rat liver development. Biochem. J. (1992) 282:209-218.
28. MULLER W, MOHR S, ZUHLKE U et al.: Alpha glutathione S transferase as biomarker for liver injury in cynomolgus monkeys - validation of a human assay. Poster presented at: The American Society of Toxicology Meeting. 25 - 29 March, San Francisco, California, USA (2001).
29. COCKERALL GL, MCKIM JM Jr, VONDERFECHT SL: Strategic importance of research support through pathology. Toxicol. Pathol. (2002) 30(1):4-7.
30. CLARKE H, EGAN DA, HEFFERNAN M et al.: α-Glutathione S-transferase (αGST) release, an early indicator of carbon tetrachloride hepatotoxicity in the rat. Hum. Exp. Toxicol. (1997) 16:154-157.
31. EASON S, MANGHANI M, GREIG G, MERZ M: Serum glutathione S-transferase alpha (αGST): a suitable biomarker for drug related liver injury? Poster presented at: The 8th World congress on clinical pharmacology and therapeutics. Brisbane, Australia (2004).
32. SIVILOTTI MLA, BIRD SB, MONTALVO M ET AL.: Serum α-glutathione S-transferase (αGST) becomes elevated shortly after subtoxic Acetaminophen overdose. Poster presented at: The Society for Academic Emergency Medicine Annual Meeting. St Louis, MO, USA (2002).
33. MAXWELL PR, SHAW M, MENDONCA C, BURDEN RD: Serum alpha glutathione S-transferase as a biomarker of methotrexate induced hepatotoxicity. Poster presented at: The 43rd annual meeting of the Society of Toxicology. Baltimore, USA (2004).
34. OHATA H, MOMOSE K, TAKAHASHI A, OMORI Y: Urinalysis for detection of chemically induced renal damage (1) - changes in urinary excretions of enzymes and various components caused by mercuric chloride and gentamicin. J. Toxicol. Sci. (1987) 12(4):341-355.
35. OHATA H, MOMOSE K, TAKAHASHI A OMORI Y: Urinalysis for detection of chemically induced renal damage (2) - changes in urinary excretions of enzymes and various components caused by p-aminophenol, puromycin aminonucleoside and hexadimethrine. J. Toxicol. Sci. (1987) 12(4):357-372.
36. STONARD MD: Assessment of nephrotoxicity. In: Animal Clinical Chemistry a primer for toxicologists. Evans GO (Ed.), Taylor & Francis Publishers, UK (1996):87-98.
37. BOSOMWORTH MP, APARICIO SR, HAY WHM: Urine N-acetyl-β-D-glucosamidase - a biomarker of tubular damage? (1999) Nephrol. Dial. Transplant. 14:620-626.
38. HARRISON DJ, KHARBANDA R, CUNNINGHAM DS, MCCLELLAN LI, HAYES JD: Glutathione S-transferase isoenzymes in the human kidney: basis for possible markers of renal injury. J. Clin Pathol. (1989) 42:624-629.
39. ROZELL B, HANSSON HA, GUTHENBERG C, TAHIR MK, MANNERVIK B: Glutathione transferases of classes alpha, mu and pi show selective expression in different regions of rat kidney. Xenobiotica (1993) 23(8):835-849.
40. SUNDBERG AGM, APPELKVIST E-L, BÄCKMAN L, DALLNER G: Quantitation of glutathione S-transferase-pi in the urine by radioimmunoassay. Nephron (1994) 66:162-169.
41. KHARASCH ED, HOFFMAN GM, THORNING D, HANKINS DC, KILTY CG: Role of renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology (1998) 88(6): 1624-1633.
42. GOLDBERG ME, CANTILLO J, GRATZ I et al.: Dose of compound A, not sevoflurane, determines changes in the biochemicad markers of renal injury in volunteers. Anesth. Analg. (1999) 88:437-445.
43. OKAMOTO K, COLLETTE W III, MONDAL M, DE PEYSTER A, STEVENS GJ: Evaluation of kidney toxicity detection methods in rat urine: GSTs by α and μGST enzyme immunoassays, metabolite profiling by NMR, and protein profiling by SELDI-TOF-MS. Poster presented at: The 44th annual meeting of the Society of Toxicology. New Orleans, USA (2005).
44. DAVIES D, BRADSHAW J, COOPE M, WESTWOOD R, KNIGHT R, MURFIN K: Novel biomarkers for the detection of regional kidney damage in the rat. Poster presented at: The EMBODY Meeting. Cambridge, UK (2000).
45. PAI MP, NORENBERG JP, TELEPAK RA, SIDNEY DS, YANG S: Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob. Agents Chemother. (2005) 49(9):3784-3788.
46. MAXWELL PR, GORDON D, COYLE A: Differentiation between renal injury and compensatory responses by the use of specific biomarkers. Poster presented at: The 43rd annual meeting of the Society of Toxicology. Baltimore, USA (2004).
47. FALKENBERG F, HILDEBRAND H, LUTTE L et al.: Urinary antigens as markers of papillary toxicity. I. Identification and characterization of rat kidney papillary antigens with monoclonal antibodies. Arch. Toxicol. (1996) 71:80-92.
48. HILDEBRAND H, RINKE M, SCHLÜTER G, BOMHARD E, FALKENBERG FW: Urinary antigens as markers of papillary toxicity. II Application of monoclonal antibodies for the determination of papillary antigens in rat urine. Arch. Toxicol. (1999) 73:233-245.